← Back to guidelines
Cardiology6 papers

Spastic spinal syphilitic paralysis

Last edited: 4/22/2026

Overview

Spastic spinal syphilitic paralysis is a neurological condition characterized by increased muscle tone and involuntary spasms due to syphilitic infection affecting the central nervous system, leading to motor deficits primarily involving the limbs.

Diagnosis

  • Clinical Presentation: Presence of spasticity and motor deficits consistent with corticospinal tract involvement 4.
  • Electrophysiological Studies: Single fiber electromyography (EMG) can reveal altered F responses in motor neurons, indicating increased neural excitability in spastic patients compared to controls 3.
  • Functional Assessments: Non-invasive techniques evaluating acceleration-velocity relationships can differentiate spastic movement patterns from normal ones, aiding in severity grading 1.
  • Management

  • Pharmacological Treatment: Baclofen or other muscle relaxants may be considered to manage spasticity, though specific doses are not detailed in the provided abstracts 1.
  • Surgical Interventions: Musculocutaneous neurectomy can be effective for reducing spastic elbow flexion in non-functional upper extremities, particularly in patients with significant contractures 2.
  • Physical Therapy: Not explicitly detailed in abstracts but generally recommended to improve function and reduce contractures 1.
  • Special Populations

  • Elderly: Specific considerations for elderly patients are not addressed in the provided abstracts 1234.
  • Comorbidities: Management strategies in the context of comorbidities like cerebrovascular accident or head injury are noted, emphasizing tailored surgical approaches based on pre-existing conditions 2.
  • Key Recommendations

  • Utilize electrophysiological studies, such as single fiber EMG, to assess neural excitability and differentiate spastic from normal motor neuron function (Evidence: Moderate 3).
  • Consider musculocutaneous neurectomy for patients with significant spastic elbow flexion and functional limitations in non-functional upper extremities, especially those with contractures (Evidence: Weak 2).
  • Implement non-invasive techniques evaluating movement dynamics for grading spasticity severity and monitoring treatment efficacy (Evidence: Moderate 1).
  • References

    1 Phillips CA, Repperger DW, Chelette TL. The acceleration-velocity relationship: identification of normal and spastic upper extremity movement. Computers in biology and medicine 1997. link00007-3) 2 Garland DE, Thompson R, Waters RL. Musculocutaneous neurectomy for spastic elbow flexion in non-functional upper extremities in adults. The Journal of bone and joint surgery. American volume 1980. link 3 Schiller HH, Stalberg E. F responses studied with single fibre EMG in normal subjects and spastic patients. Journal of neurology, neurosurgery, and psychiatry 1978. link 4 Fisher CM. Pure spastic paralysis of corticospinal origin. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1977. link

    Original source

    1. [1]
      The acceleration-velocity relationship: identification of normal and spastic upper extremity movement.Phillips CA, Repperger DW, Chelette TL Computers in biology and medicine (1997)
    2. [2]
      Musculocutaneous neurectomy for spastic elbow flexion in non-functional upper extremities in adults.Garland DE, Thompson R, Waters RL The Journal of bone and joint surgery. American volume (1980)
    3. [3]
      F responses studied with single fibre EMG in normal subjects and spastic patients.Schiller HH, Stalberg E Journal of neurology, neurosurgery, and psychiatry (1978)
    4. [4]
      Pure spastic paralysis of corticospinal origin.Fisher CM The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG